The global Reprocessed Medical Devices Market is estimated to be valued at US$ 3722.53 Mn in 2023 and is expected to exhibit a CAGR of 20.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Reprocessed medical devices refer to previously used medical devices that are reprocessed, inspected, tested and resterilized for reuse to reduce healthcare costs. Reprocessed medical devices include products such as orthopedic implants, cardiology and general surgery equipment. These are generally less expensive than new equipment and provide wider access to advanced medical technology for healthcare facilities.

Market key trends:
One of the key trends driving the growth of the reprocessed medical devices market is rising adoption of telemedicine. Telemedicine uses digital information and communication technologies to facilitate remote clinical healthcare and help physicians consult patients who are located miles away. This has significantly improved access to quality healthcare across urban and rural areas globally. According to a survey, around 1 in 5 physicians in the US have adopted telehealth services. Growing demand for affordable medical treatments and rising adoption of telemedicine are some of the factors fueling the growth of the reprocessed medical devices market globally during the forecast period.
Segment Analysis
The global reprocessed medical devices market is segmented into device and end user. Based on device, cardiovascular devices dominate the market and is expected to witness highest growth during the forecast period. Cardiovascular devices segment held more than 35% market share in 2023. The dominance is attributed to rising burden of cardiovascular diseases worldwide and increasing adoption of reprocessed cardiovascular devices such as balloon catheters, guidewires and cardiac ablation catheters by hospitals and clinics to reduce healthcare costs.

Key Takeaways
The global Reprocessed Medical Devices Market Share is expected to witness high growth, exhibiting CAGR of 20.% over the forecast period, due to increasing healthcare costs and focus on reducing unnecessary medical expenses.

The market size for reprocessed medical devices is expected to reach US$ 3722.53 Mn in 2023. North America dominated the global market in 2023 and is expected to maintain its dominance during the forecast period. This is attributed to growing awareness about reprocessed medical devices and supportive regulatory policies in the region. Europe market is growing at fastest pace due to increasing need to provide affordable healthcare.

Key players operating in the reprocessed medical devices market are Stryker Corporation, Johnson & Johnson, Vanguard AG, Medline ReNewal , SteriPro Canada, Inc., Pioneer Medical Devices AG, Vascular Solutions, Inc., HYGIA Health Services, Inc., ReNu Medical, Inc., SureTek Medical, and Centurion Medical Products Corporation. Stryker Corporation held around 20% of global market share in 2023 due to its wide portfolio of reprocessed orthopedic and cardiovascular medical devices.

Read More,

https://www.insightprobing.com/reprocessed-medical-devices-market-trends-size-and-share-analysis/